🏥 Health Nov 14, 2022

Experimental therapy gantenerumab fails to slow or improve Alzheimer's memory loss in clinical trials

CNN Health
View Channel →
Source ↗ 👁 21 💬 0
An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer's or those who were in the early phases of the disease, the manufacturer said Monday.

Comments (0)

Sign in to join the discussion

More Like This

STAT+: Ionis Pharmaceuticals shares plummet after slow rollout of biotech’s triglyceride-lowering drug
STAT · 2d ago
Common Antibiotic Tied to Pregnancy Loss Risk
MedPageToday.com - medical news for physicians · 2d ago
Smartwatch Detection of Reduced LVEF? Not So Fast, Study Says.
MedPageToday.com - medical news for physicians · 2d ago
Police Investigate After 25 Half-Marathon Runners Seek Medical Care
MedPageToday.com - medical news for physicians · 2d ago
📰
DAISY Award spotlight: ‘She turned the most painful day of our lives into ones filled with love, honor, and peace for our baby boy.’
Vanderbilt Health News · 2d ago
Early Response to MASH Drug Linked to Resolution, Fibrosis Improvement
MedPageToday.com - medical news for physicians · 2d ago